XBiotech Says IND Application For V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path For U.S. Patient Enrollment
XBiotech Inc XBIT
$2.33
▼ -1.69%
($-0.04)
Open
$2.39
Prev Close
$2.37
Day Range
$2.31 – $2.39
52W Range
$2.09 – $3.61
Market Cap
$71.65M
Beta
0.85
EPS (TTM)
$-1.32
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2015-04-15 |
| Shares Out. | 30,490,000 |
| Website | xbiotech.com/ ↗ |
| Phone | 15123862900 |
XBiotech Inc is a publicly traded company under the ticker symbol XBIT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2021-12-01)